News

C.W. Downer & Co. Advises Lydall, Inc. on Sale of Charter Medical Ltd.

BOSTON, February 24, 2015 – C.W. Downer & Co., a leading global middle-market investment bank, is pleased to announce that Lydall, Inc. (NYSE:LDL) has sold Charter Medical Ltd. to a US subsidiary of Fenner PLC (LSE:FENR), for $29.9 million. The deal closed on January 30, 2015.

Based in Winston-Salem, North Carolina, Charter Medical is a leading designer and manufacturer of customized, single-use medical devices and bio-containers for the collection, processing, storage and filtration of biological and bioprocessing fluids. These products are used in a variety of medical and life science applications including biopharmaceutical manufacturing, stem cell cryogenic freezing, blood transfusion and blood filtration. Charter Medical will join Solesis Medical Technologies which comprises the medical activities of Fenner’s Advanced Engineered Products (AEP) division.

“We are very pleased to announce the successful divestiture of Charter Medical on behalf of our client Lydall,” said Joshua Garver, Vice President with C.W. Downer & Co. “Charter’s single-use products for bioprocessing and cell therapy applications are poised for significant growth and Solesis Medical should provide an excellent platform to support the future expansion of Charter’s business. We wish Solesis future success with the acquisition.”

“We are proud to have completed this transaction through a disciplined and efficient process that yielded an attractive outcome for our client,” said Paul Colone, Managing Director & Partner with C.W. Downer & Co. “This deal represents the third successful transaction that we have completed with Lydall and we are appreciative of the partnership that we have developed with their executive team,” he concluded.

The C.W. Downer & Co. team advising Lydall on the divestiture included Mr. Colone, Mr. Garver, Antoine Telle (Associate) and Nick Virga (Analyst). C.W. Downer also assisted Lydall on the 2014 acquisition of Andrew Filtration and the 2011 sale of Lydall Industrial Thermal Solutions, Inc. (“Affinity”) to Lytron, Inc.

About C.W. Downer & Co.

C.W. Downer & Co. is an independent, global investment bank offering middle-market clients a high level of personal attention coupled with 40 years of international execution experience. We provide insight, not just information. We generate value, not just transactions. With nine fully integrated offices on four continents, we consistently identify the most appropriate strategic buyer and uncover hidden acquisition targets. C.W. Downer & Co. delivers the reach of a bulge-bracket investment bank with the senior level focus of a boutique. For more information, visit http://www.cwdowner.com.

For Further Information:

Paul Colone, Managing Director & Partner
This email address is being protected from spambots. You need JavaScript enabled to view it.
C.W. Downer & Co.
+1 617 482 6200

Back to Previous

© 2015 by C.W. Downer & Co.

Downer & Company (d/b/a C.W. Downer & Co.) is a fully registered broker/dealer
and a member of the Financial Industry Regulatory Authority (FINRA).